At the time of writing, Ideaya Biosciences Inc [IDYA] stock is trading at $22.58, up 0.44%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IDYA shares have gain 6.71% over the last week, with a monthly amount glided 3.01%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wells Fargo started tracking the stock with Overweight rating on June 26, 2025, and set its price target to $44. On November 18, 2024, Stephens initiated with a Overweight rating and assigned a price target of $51 on the stock. Leerink Partners downgraded its rating to a Market Perform but stick to its price target of $27 on November 05, 2024. UBS initiated its recommendation with a Buy and recommended $50 as its price target on October 24, 2024. In a note dated July 08, 2024, Mizuho initiated an Outperform rating and provided a target price of $50 on this stock.
For the past year, the stock price of Ideaya Biosciences Inc fluctuated between $13.45 and $44.42. Currently, Wall Street analysts expect the stock to reach $46.58 within the next 12 months. Ideaya Biosciences Inc [NASDAQ: IDYA] shares were valued at $22.58 at the most recent close of the market. An investor can expect a potential return of 106.29% based on the average IDYA price forecast.
Analyzing the IDYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -51.48%, Pretax Profit Margin comes in at -43.76%, and Net Profit Margin reading is -43.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.29 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.28 points at the first support level, and at 21.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.88, and for the 2nd resistance point, it is at 23.18.
Ratios To Look Out For
It is important to note that Ideaya Biosciences Inc [NASDAQ:IDYA] has a current ratio of 13.92. In addition, the Quick Ratio stands at 13.92 and the Cash Ratio stands at 2.56. Considering the valuation of this stock, the price to sales ratio is 282.51, the price to book ratio is 1.93.
Transactions by insiders
Recent insider trading involved Jason Throne, Former Officer, that happened on Aug 26 ’24 when 75000.0 shares were purchased.
